TY - JOUR T1 - Unusual uterine metastasis of plasmablastic lenfoma: a case report AU - Karataş, Suat AU - Çift, Tayfur AU - Şal, Veysel AU - Tekelioğlu, Meltem AU - Ton, Özlem PY - 2019 DA - November Y2 - 2019 DO - 10.18621/eurj.455365 JF - The European Research Journal JO - Eur Res J PB - Prusa Medical Publishing WT - DergiPark SN - 2149-3189 SP - 1020 EP - 1023 VL - 5 IS - 6 LA - en AB - Plasmablasticlenfoma (PBL) is a diffuse large B-cell lymphoma (DLBCL)’s variant form that isespecially reported in HIV-infected patients. PBL is a rare entity seen mostcommonly in the setting of immunocompromise. However, this disease may presentin extraoral sites in which the genital tract appears to be the less common. Herewe present a patient with uterine and fallopian mass diagnosed PBL. A 51-year-oldmultipara (G6P4C2) woman with a chief complaint of irregular vaginal bleedingwas presented to our outpatient clinic. She had a prior history of breastcancer treated by right mastectomy and adjuvant chemotherapy.Transvaginalultrasonography and magnetic resonance imaging both showed an uterine massthought to be leiomyoma, which 4×3 cm in size on the anterior wall of uterincorpus. The pathology result of the mass was found to be plasmablasticlymphoma. Genital involvement also appears to be last but possible site option tofind PBL focus in immunocompetent patients. KW - Plasmablastic lymphoma KW - uterine mass KW - surgery CR - [1] El Fakih R, Almahayni M, Alsermani M. Plasmablastic lymphoma presenting as exophytic skin lesions. Hematol Oncol Stem Cell Ther 2017;10:164-5. CR - [2] Delecluse HJ, Anagnostopoulos I, Dallenbach F, Hummel M, Marafioti T, Schneider U, et al. Plasmablastic lymphomas of the oral cavity: a new entity associated with the human immunodeficiency virus infection. Blood 1997:15;89:1413-20. CR - [3] Lee OJ, Kim KW, Lee GK. Epstein-Barr virus and human immunodeficiency virus-negative oral plasmablastic lymphoma. J Oral Pathol Med 2006;35:382-4. CR - [4] Swerdlow SH, Campo E, Pileri SA, Harris NL, Stein H, Siebert R, et al. The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood 2016;127:2375-90. CR - [5] Morton LM, Wang SS, Devesa SS, Hartge P, Weisenburger DD, Linet MS. Lymphoma incidence patterns by WHO subtype in the United States, 1992-2001. Blood 2006;107:265-76. CR - [6] Dittus C, Sarosiek S. A case of HIV-negative plasmablastic lymphoma of the bone marrow with a unique immunophenotype. Clin Case Rep 2017;5:902-4. CR - [7] Han X, Duan M, Hu L, Zhou D, Zhang W. Plasmablastic lymphoma: Review of 60 Chinese cases and prognosis analysis. Medicine (Baltimore) 2017;96:e5981. CR - [8] Gong J, Alkan S, Anand S. A case of cutaneous plasmablastic lymphoma in HIV/AIDS with disseminated cryptococcus. Case Rep Oncol Med 2013;2013:862585. CR - [9] Rafaniello Raviele P, Pruneri G, Maiorano E. Plasmablastic lymphoma: a review. Oral Dis 2009;15:38-45. CR - [10] Komaranchath AS, Haleshappa RA, Kuntegowdenahalli LC, Kumar RV, Dasappa L, Babu G. Plasmablastic lymphoma of the gastrointestinal tract: A rare entity with a dismal prognosis. Indian J Cancer 2016;53:529-33. UR - https://doi.org/10.18621/eurj.455365 L1 - https://dergipark.org.tr/en/download/article-file/773533 ER -